한글목차

세계의 뼈 및 관절 재생의료 시장 규모는 2022년 96억 달러, 2023년 107억 달러에서 2023년부터 2028년까지 예측기간 중 12.1%의 CAGR로 성장하여 2028년에는 189억 달러 규모로 성장할 것으로 예측됩니다.

바이오소재 기술 부문은 2023년 64억 달러에서 11.3%의 CAGR로 성장하여 2028년에는 110억 3,000만 달러 규모로 성장할 것으로 예측됩니다. 또한 조직공학 부문은 2023년 27억 달러에서 13.3%의 CAGR로 성장하여 2028년에는 50억 4,000만 달러 규모로 성장할 것으로 예측됩니다.

세계의 뼈 및 관절 재생의료 시장을 조사했으며, 시장 및 기술 배경, 시장 영향요인과 시장 기회 분석, 규제 상황, 시장 규모 추정과 예측, 각종 부문·지역별 상세 분석, 특허 동향, 경쟁 환경, 주요 기업 개요 등을 정리했습니다.

목차

제1장 서론

제2장 요약과 하이라이트

제3장 시장과 기술 배경

• 재생의료 개요
• 재생의료는 어떻게 기능하는가?
• 재생의료의 주요 접근법
• 세포와 조직
• 조직공학
• 조직공학에서 스캐폴딩의 중요성
• 플라스틱 스캐폴딩
• 혈관 스캐폴딩
• CIMIT(Center for Integration of Medicine and Innovative Technology)
• 배아줄기세포

제4장 시장의 신흥/향후 기술

• 뼈 및 관절 재생의료의 최신 기술 응용
• 정형외과의 나노재료와 재생의료
• 줄기세포와 나노미터 기술을 이용한 재생의료
• 나노구조 연골 조직 공학
• 골 조직공학
• 건 조직공학
• 지방조직
• 혈소판풍부혈장(PRP)
• 다세포/다물질 조직 구축을 위한 바이오프린팅 기술
• 조직공학의 스캐폴딩 옵션
• 하이드로겔 스캐폴드
• 고체 스캐폴드
• 향후 기회

제5장 시장 역학

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• COVID-19의 영향 분석

제6장 시장 내역 : 기술별

• 세계 시장 : 기술별
• 바이오소재
• 재생용 바이오소재
• 시장 규모와 예측
• 조직공학
• 시장 규모와 예측
• 줄기세포 치료
• 시장 규모와 예측

제7장 시장 내역 : 용도별

• 세계 시장 : 용도별
• 동종뼈
• 시장 규모와 예측
• 자가뼈
• 시장 규모와 예측
• 골이식편 대체품
• 시장 규모와 예측
• 골관절 질환
• 시장 규모와 예측
• 기타 질병
• 시장 규모와 예측

제8장 시장 내역 : 지역별

• 세계 시장 : 지역별
• 북미
• 미국
• 캐나다
• 유럽
• 독일
• 프랑스
• 영국
• 이탈리아
• 러시아
• 스페인
• 기타 유럽
• 아시아태평양
• 중국
• 일본
• 호주
• 인도
• 기타 아시아태평양
• 기타 지역
• 시장 규모와 예측

제9장 규제 환경

• 뼈 및 관절 재생의료의 신규 승인과 승인 가속

제10장 특허 리뷰·새로운 개발

제11장 경쟁 상황

• M&A·계약
• 제품 발매
• 제조업체·시장 점유율 분석

제12장 기업 개요

• ANIKA THERAPEUTICS INC.
• ARTHREX INC.
• BAXTER INTERNATIONAL INC.
• BIOVENTUS
• CONMED CORP.
• DEPUY SYNTHES PRODUCTS INC.
• MEDTRONIC PLC
• ROYAL BIOLOGICS
• SEIKAGAKU CORP.
• SMITH & NEPHEW PLC
• STRYKER CORP.
• ZIMMER BIOMET HOLDINGS INC.

제13장 부록 : 두문자어 리스트

영문목차

Highlights:

The global market for regenerative medicine in bone and joint applications reached $9.6 billion in 2022. The market is estimated to increase from $10.7 billion in 2023 to $18.9 billion by 2028, at a compound annual growth rate (CAGR) of 12.1% from 2023 through 2028.

The biomaterials technology segment in the global market for regenerative medicine in bone and joint applications is estimated to increase from $6.4 billion in 2023 to $11.03 billion by 2028, at a CAGR of 11.3% from 2023 through 2028.

The tissue engineering segment in the global market for regenerative medicine in bone and joint applications is estimated to increase from $2.7 billion in 2023 to $5.04 billion by 2028, at a CAGR of 13.3% from 2023 through 2028.

Report Scope:

The report explains critical trends in the regenerative medicine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.

This study looks at most of the systems affected by factors such as R&D spending and increasing competition and new technologies.

This report also covers merger and acquisition strategies and collaborations, as well as the strengths and weaknesses of each strategy type.

The market has also been analyzed based on regenerative medicine for bone and joint applications. Categories considered in this report include allogeneic bones, autogenic bones, bone graft substitutes, osteoarticular diseases, and others.

The report provides information to all market players, potential entrants, government agencies, and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.

Report Includes:

• 36 data tables and 30 additional tables
• An up-to-date review and in-depth assessment of the global markets for regenerative medicine in bone and joint applications
• Analyses of the global market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimation of the actual market size and revenue forecast for regenerative medicine for bone and joint applications market, and corresponding market share analysis based on the type of technology, application, and region
• Highlights of the importance of biomaterials, stem cell therapy, tissue engineering, and emerging/upcoming technologies (including bioprinting) in the regenerative medicine industry, along with the long-term impacts of regenerative medicine technologies, both existing and in developmental stage
• Country specific data analysis and market growth forecasts for the U.S., Canada, Germany, the UK, France, Italy, Russia, Spain, Australia, Japan, China and India
• Discussion of major growth drivers and restraints, technology advancements, product innovations and regulatory aspects that will shape the market for regenerative medicine for bone and joint applications as a basis for projecting demand in the next few years (2023-2028)
• Identification of the companies best positioned to meet this demand owing to or in conjunction with their proprietary technologies, product launches, and other strategic advantages
• Holistic review of the impact of COVID-19 and other economic and demographic factors affecting the market growth in the analysis period
• A relevant patent analysis with the number of patents registered/approved, ongoing industry clinical trials, and recent mergers, acquisitions, and collaboration agreements in the regenerative medicine industry
• Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on global R&D activities, market growth strategies, and company revenue share analysis
• Identification of leading and emerging competitors in the global regenerative medicine market, and analysis of competitive landscape based on recent developments and segmental revenues
• Company profiles descriptions of the major market players, including Smith & Nephew Plc, DePuy Synthes, Medtronic plc, Stryker Corp., Bioventus, Zimmer Biomet, Anika Therapeutics, Baxter Intl., and CONMED Corp.

Table of Contents

Chapter 1 Introduction

• Background
• Study Goals and Objectives
• Reasons for Doing This Study
• What's New in This Update?
• Scope of Report
• Information Sources
• Research Methodology
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

• Overview of Regenerative Medicine
• How Regenerative Medicine Works?
• Principal Approaches to Regenerative Medicine
• Cells and Tissues
• Tissue Engineering
• Importance of Scaffolding in Tissue Engineering
• Plastic Scaffolding
• Blood Vessel Scaffolding
• Center for Integration of Medicine and Innovative Technology (CIMIT)
• Embryonic Stem Cells

Chapter 4 Emerging/Upcoming Technologies in the Market

• Emerging Technologies in Regenerative Medicines for Bones and Joint Applications
• Nanomaterials and Regenerative Medicine in Orthopedic Surgery
• Regeneration Therapy Using Stem Cells and Nanometer Technology
• Nanostructured Cartilage Tissue Engineering
• Bone Tissue Engineering
• Tendon Tissue Engineering
• Adipose Tissue
• Platelet-Rich-Plasma (PRP)
• Bioprinting Technologies for Construction of Multicellular/Multi-material Tissues
• Scaffolding Option in Tissue Engineering
• Hydrogel Scaffold
• Solid Scaffold
• Future Opportunities

Chapter 5 Market Dynamics

• Market Drivers
• Growing Number of Bone and Joint Disorders and Orthopedic Surgeries
• Increasing Expenditures for Health Care and Investments in Regenerative Medicines
• Increasing Geriatric Population
• Increasing Product Approvals and Launches
• R&D for Stem and Gene Therapies
• Market Restraints
• Stringent Government Regulatory Settings in R&D
• Market Opportunities
• Growing Pipeline for Regenerative Medicines
• COVID-19 Impact Analysis
• Impact of COVID-19 on the Market for Cell and Gene Therapies and Regenerative Medicine for Bone and Joint Applications
• Direct Impact on Clinical Trials in Cell and Gene Therapy
• Post-COVID-19 Effect on Regenerative Medicine for Bones and Joint Applications

Chapter 6 Market Breakdown by Technology

• Global Market, by Technology
• Biomaterials
• Biomaterials for Regeneration
• Market Size and Forecast
• Tissue Engineering
• Market Size and Forecast
• Stem Cell Therapy
• Market Size and Forecast

Chapter 7 Market Breakdown by Application

• Global Market, by Application
• Allogeneic Bones
• Market Size and Forecast
• Autogenic Bones
• Market Size and Forecast
• Bone Graft Substitutes
• Market Size and Forecast
• Osteoarticular Diseases
• Market Size and Forecast
• Other Diseases
• Market Size and Forecast

Chapter 8 Market Breakdown by Region

• Global Market, by Region
• North America
• United States
• Canada
• Europe
• Germany
• France
• United Kingdom
• Italy
• Russia
• Spain
• Rest of Europe
• Asia-Pacific
• China
• Japan
• Australia
• India
• Rest of Asia-Pacific
• Rest of the World
• Market Size and Forecast

Chapter 9 Regulatory Aspects

• New and Accelerated Approvals of Regenerative Medicine for Bones and Joint Applications

Chapter 10 Patent Review/New Developments

• Patent Analysis, by Year

Chapter 11 Competitive Landscape

• Mergers, Acquisitions, and Agreements
• Product Launches
• Manufacturers of Regenerative Medicine for Bones and Joint Applications and their Market Share Analysis

Chapter 12 Company Profiles

• ANIKA THERAPEUTICS INC.
• ARTHREX INC.
• BAXTER INTERNATIONAL INC.
• BIOVENTUS
• CONMED CORP.
• DEPUY SYNTHES PRODUCTS INC. (PART OF JOHNSON & JOHNSON)
• MEDTRONIC PLC
• ROYAL BIOLOGICS
• SEIKAGAKU CORP.
• SMITH & NEPHEW PLC
• STRYKER CORP.
• ZIMMER BIOMET HOLDINGS INC.

Chapter 13 Appendix: List of Acronyms